10 New Drugs for Primary Care: Q2 2018

Slideshow

What new drugs should you know about from the second quarter of 2018? Scroll through our quick slideshow to find out.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
FDA Approves Semaglutide 2.4 mg for Treatment of MASH Without Cirrhosis

FDA Approves Semaglutide 2.4 mg for Treatment of MASH Without Cirrhosis

Patient Care Editorial Staff
August 17th 2025
Article
The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

Sydney Jennings
August 17th 2025
Podcast
Guideline Topline: 2025 AHA/ACC Hypertension / image credit Dan Jones, MD, University of Mississippi Foundation

AHA/ACC Release Revised Hypertension Clinical Practice Guidelines to Reduce CVD Risk

Grace Halsey
August 17th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 17th 2025
Podcast
GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NHIS Data Brief / image credit ©Sebastian Garcia/stock.adobe.com

GLP-1 RAs Prescribed for More Than One-Third of US Adults With Diabetes in Middle Age: NCHS Data Brief

Grace Halsey
August 17th 2025
Article
Lecanemab Shows Sustained Benefit at 4 Years in Early Alzheimer Disease: Daily Dose / image credit: ©New Africa/AdobeStock

Lecanemab Shows Sustained Benefit at 4 Years in Early Alzheimer Disease: Daily Dose

Sydney Jennings
August 17th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.